Variant report
Variant | esv3404430 |
---|---|
Chromosome Location | chr17:66953582-66956130 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ABCA8 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375022890 | chr17:66953594-66953595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs28450507 | chr17:66953601-66953602 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs569354156 | chr17:66953608-66953609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140951761 | chr17:66953620-66953621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560951464 | chr17:66953623-66953624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9897075 | chr17:66953629-66953630 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs549906247 | chr17:66953659-66953660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571827050 | chr17:66953693-66953694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534347312 | chr17:66953701-66953702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532794480 | chr17:66953714-66953715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548089020 | chr17:66953722-66953723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62087825 | chr17:66953786-66953787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs372923508 | chr17:66953791-66953792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187927351 | chr17:66953844-66953845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138095777 | chr17:66953869-66953870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11868372 | chr17:66953909-66953910 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs11869992 | chr17:66954003-66954004 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs142243408 | chr17:66954013-66954014 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs577411362 | chr17:66954031-66954032 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs538473628 | chr17:66954047-66954048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555364281 | chr17:66954048-66954049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554015165 | chr17:66954074-66954075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530208915 | chr17:66954082-66954083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573846350 | chr17:66954199-66954200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542930118 | chr17:66954327-66954328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200385654 | chr17:66954333-66954334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76778067 | chr17:66954337-66954338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75928061 | chr17:66954338-66954339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560674835 | chr17:66954390-66954391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145966265 | chr17:66954392-66954393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543534092 | chr17:66954452-66954453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547985138 | chr17:66954541-66954542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565002399 | chr17:66954556-66954557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532739289 | chr17:66954557-66954558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs56049464 | chr17:66954558-66954559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556498674 | chr17:66954563-66954564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547642583 | chr17:66954565-66954566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61564908 | chr17:66954566-66954567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371822473 | chr17:66954578-66954579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs59677045 | chr17:66954586-66954587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559918705 | chr17:66954599-66954600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534670440 | chr17:66954615-66954616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs56315302 | chr17:66954675-66954676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs60329109 | chr17:66954682-66954683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs59020171 | chr17:66954684-66954685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs57927903 | chr17:66954689-66954690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs55985476 | chr17:66954704-66954705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372548002 | chr17:66954731-66954732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72190063 | chr17:66954732-66954733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71144643 | chr17:66954738-66954739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Congenital generalized hypertrichosis terminalis | 19463983 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Gingival hyperplasia | 19463983 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16417655 | CNVD |
Breast cancer | 21045282 | CNVD |
Epilepsy | 22083797 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Honadal dysgenesis | 21408189 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:66952000-66957000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr17:66952000-66957000 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr17:66952000-66957000 | Weak transcription | Brain Cingulate Gyrus | brain |
4 | chr17:66952000-66957200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr17:66952000-66957400 | Weak transcription | Adipose Nuclei | Adipose |
6 | chr17:66955600-66957400 | Weak transcription | Brain Hippocampus Middle | brain |